Small B-cell Neoplasms – Rebecca King, MD
Section: 1 Presentation 1 Document
USCAP Update On Hematopathology Classification The International Consensus Classification Perspective 2023
+ Include: videos + pdf, size: GB
Course Audience: pathologist
Overview:
Original release date: November 17, 2023
Course Description
The diagnosis and classification of hematopoietic tumors is increasingly complex and evolves rapidly. The introduction of the International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms and publication of the proposed 5th edition World Health Organization (WHO) classification of the same tumors is the latest stage in this evolution and both further expand the clinical, morphologic, immunophenotypic and molecular genetic criteria for diagnosis. Join USCAP and learn from developers of the ICC on what is new in the classification of these tumors and how the ICC and proposed WHO compare. Leading clinical experts in hematology/oncology will also provide clinician perspectives on the importance of proper disease classification. The course will include disease specific lectures as well as opportunities to join experts in interactive microscopy sessions to gain practical knowledge on how to implement the new disease classifications into practice.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- Familiarize the attendee with the process for developing the International Consensus Classification of Myeloid and Lymphoid Neoplasms
- Discuss diagnostic criteria for major hematopoietic tumor disease categories
- Learn how to implement molecular genetic testing into the diagnosis and classification of hematologic neoplasms
Lymphoplasmacytic Lymphoma, Myeloma and Related Neoplasms – James Cook, MD, PhD
Section: 1 Presentation 1 Document
Cutaneous Lymphomas – John Goodlad, MD, MBChB, FRCPath
Section: 1 Presentation 1 Document
Clinician Perspective on the Diagnosis of B-cell Lymphoma – Jane Winter, MD
Section: 1 Presentation 1 Document
Aggressive B-cell Lymphomas – Elias Campo, MD, PhD
Section: 1 Presentation 1 Document
Hodgkin Lymphoma and Grey Zone Lymphomas – Elias Campo, MD, PhD
Section: 1 Presentation 1 Document
T-cell Lymphoma – Leticia Quintanilla-Fend, MD
Section: 2 Presentations 1 Document
Molecular Approach to Malignant Lymphoma – Laurence de Leval, MD, PhD
Section: 1 Presentation 1 Document
Clinician Perspective on the Diagnosis of T-cell Neoplasms – Steve Horwitz, MD
Section: 1 Presentation 1 Document
Immunodeficiency-associated Lymphoproliferative Disorders – Elaine Jaffe, MD
Section: 1 Presentation 1 Document
Histiocytic and Dendritic Cell Neoplasms – Elaine Jaffe, MD
Section: 1 Presentation 1 Document
Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage – Michael Borowitz, MD, PhD
Section: 1 Presentation 1 Document
Clonal Hematopoiesis and Myelodysplastic Syndromes – Robert Hasserjian, MD
Section: 1 Presentation 1 Document
Myeloproliferative Neoplasms – Hans-Michael Kvasnicka, MD, PhD
Section: 1 Presentation 1 Document
Mastocytosis – Attilio Orazi, MD, FRCPath
Section: 1 Presentation 1 Document
Clinician Perspective on the Diagnosis of Eosinophilic and Mast Cell Disorders – Ayalew Tefferi, MD
Section: 1 Presentation 1 Document
Myeloid/lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions – Sa Wang, MD
Section: 1 Presentation 1 Document
Myelodysplastic/myeloproliferative Neoplasms – Attilio Orazi, MD, FRCPath
Section: 1 Presentation 1 Document
Pediatric and/or Germline Disorders – Katherine Calvo, MD, PhD
Section: 1 Presentation 1 Document
Acute Myeloid Leukemia – Daniel Arber, MD
Section: 1 Presentation 1 Document
Clinician Perspective on the Diagnosis of Acute Myeloid Leukemia – Olatoyosi Odenike, MD
Section: 1 Presentation 1 Document
Molecular Approach to Myeloid Disorders – Adam Bagg, MD
Section: 1 Presentation 1 Document